Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W20 AI cyclic peptide drug discovery with Bristol Myers Squibb collaboration May 2024; $4.15M Khosla/Uncork/Feld-backed using ML+quantum computing for peptide optimization competing with Relay Therapeutics for pharma licensing.
Menten AI is a San Francisco-based AI drug discovery company — backed by Y Combinator (W20) with $4.15 million in total funding from Y Combinator, Khosla Ventures, Uncork Capital, Feld Ventures, Mana Ventures, Quain Investments, Society Health, and Volpini Ventures — developing peptide and protein therapeutics using machine learning and quantum computing to design novel cyclic peptide drug candidates for pharmaceutical licensing partnerships, completing a research collaboration with Bristol Myers Squibb in May 2024. Founded in 2018, Menten AI applies advanced AI algorithms for cyclic peptide optimization and protein structure design with a business model centered on licensing proprietary algorithms and drug candidates to pharma partners rather than developing therapeutics through full clinical development.
German craftsman AI voice agent answering calls and scheduling 24/7 for 1M+ Handwerk businesses; YC-backed targeting phone automation for HVAC, plumbing, and electrical trades in Germany.
Hey Telo is a Berlin-based AI voice agent company building phone-answering and administrative automation specifically for Germany's 1 million+ independent craftsman businesses (Handwerksbetriebe) — HVAC technicians, plumbers, electricians, carpenters, and other skilled trades — who lose significant revenue daily to unanswered calls and administrative burden. A Y Combinator-backed startup, Hey Telo provides voice AI agents that answer calls professionally 24/7, schedule appointments, and provide quotes while the craftsman is on-site working.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.